Liver Health

Other Combinations

Brand: Emerald

CapsuleOff Market

Product label for Liver Health — Click to view full label

Net Contents

90 Vegetable Cap(s)

Serving Size

3 Capsule(s)

Servings Per Container

Not specified

Supplement Form

Capsule

Bar Code (UPC/SKU)

7 43650 00218 4

Product Version

Not specified

Suggested Use

Suggested Use: Take one (1) capsule with each meal or for more intensive support; take 2 with each meal.

Market Reference

$1.49 – $359.00· 40 listings

Emerald Laboratories Liver Health 60 Vegetable Capsules
Healthquest Vitamins4.7(31)
$37.95
Emerald Laboratories European Milk Thistle
Herbs Direct4.8(37)
$22.46
Snap Supplements Liver Health & Detox
Snap Supplements4.9(39)
$154.95
Emerald Laboratories Pea+ with Enhanced LipiSperse
Fruitful Yield4.7(48)
$44.06
Emerald Cleanse
vitalistfresh.com
$72.00
Raw Emerald Stone
New Moon Beginnings
$1.49Lowest
European Milk Thistle, 60 Veg Capsules, by Emerald
Natural Healthy Concepts4.8(37)
$22.99
Global Healing Liver Health
Instacart4.7(1200)
$28.99

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Boundless Nutrition
5.0 (60)
Vitamin & supplements store
54 Washington Ave, Pleasantville, NY 10570
Directions (914) 801-9252
The Vitamin Shoppe
4.4 (99)
Vitamin & supplements store
455 Central Ave, White Plains, NY 10606
Directions (914) 948-1048
Green Vitamin Store
5.0 (9)
Vitamin & supplements store
265 S Central Ave, Hartsdale, NY 10530
Directions (914) 437-8645
A-Z Nutrition&Smoothies
4.9 (64)
Health food store
2562 Central Park Ave, Yonkers, NY 10710
Directions (914) 337-1519
Green’s Natural Foods Mt. Kisco
4.2 (200)
Vitamin & supplements store
666 Lexington Ave #1, Mt Kisco, NY 10549
Directions (914) 864-1274
Regal Supplements
5.0 (1)
Vitamin & supplements store
159 NY-303, Valley Cottage, NY 10989
Directions (845) 536-5511
Jiva Supplements
Vitamin & supplements store
487 E Main St, Mt Kisco, NY 10549
Directions (877) 737-8184
The Vitamin Shoppe
4.7 (72)
Vitamin & supplements store
3025 E Main St, Cortlandt Manor, NY 10567
Directions (914) 526-4145

Research & Studies

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind …
B Sangro, M Kudo, JP Erinjeri, S Qin, Z Ren, SL Chan… - The Lancet, 2025 - thelancet.com
… , and the competing risk of death from underlying liver disease could confound overall survival results. … The phase 3 EMERALD-1 study was designed to assess the efficacy and safety of …
2025289 citations
A synthetic receptor platform enables rapid and portable monitoring of liver dysfunction via engineered bacteria
HJ Chang, A Zuniga, I Conejero, PL Voyvodic, J Gracy… - bioRxiv, 2021 - biorxiv.org
… We applied EMeRALD to detect bile salts, a biomarker of liver dysfunction, by repurposing … undergone liver transplant, providing an output detectable by the naked-eye. The EMeRALD …
2021
Unexplained early deaths in EMERALD-1: is liver failure the reason?–Authors' reply
B Sangro, SL Chan - The Lancet, 2025 - thelancet.com
… We read with great interest the Article on the EMERALD-1 trial.… Given that the rate of deaths due to liver impairment should … residual liver function, potentially leading to liver failure. This …
2025
1437 Analysis by treatment period and liver function in EMERALD-1: a phase 3 study of durvalumab±bevacizumab+ TACE in participants with embolization-eligible …
SL Chan, M Kudo, T Decaens, JP Erinjeri, S Qin, Z Ren… - 2024 - jitc.bmj.com
Background The Phase 3 EMERALD-1 study ( NCT03778957) met its primary endpoint: durvalumab+bevacizumab+transarterial chemoembolization (TACE) significantly improved …
2024
P67 Audit on terlipressin use and complications in cirrhosis and hepatorenal syndrome-acute kidney injury (HRS-AKI)
H Hesketh, A Singanayagam - 2025 - gut.bmj.com
… Conclusion Our survey shows that most doctors value healthcare bundles and … EMERALD, a Phase1/ 2 trial, aims to evaluate engineered macrophages in patients with end stage liver …
2025
166P Outcomes by baseline liver function in EMERALD-1: A phase III, randomised, placebo (PBO)-controlled study of durvalumab (D) with or without bevacizumab (B) …
SL Chan, T Decaens, M Kudo, JP Erinjeri… - Annals of …, 2024 - annalsofoncology.org
… liver function is often impaired; TACE may further deteriorate liver function and the underlying liver … Here, we evaluated the efficacy and safety of D + B + TACE by liver function in uHCC. …
20241 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2018-09-21. DSLD Label ID: 181340. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.